STEVEN MONTANA D.O. NPI 1225034788

NPI Details

Steven Montana, D.O. is a hematology and oncology internal medicine in East Setauket, NY with 34 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. Steven Montana, D.O. NPI is 1225034788. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: NEW YORK COLLEGE OF OSTEO MEDICINE OF NEW YORK INSTITUTE OF TECHNOLOGY
Graduation Year:1992

The provider's business location address is:

235 N BELLE MEAD RD
EAST SETAUKET, NY
ZIP 11733-456
Phone: (631) 751-3000
Fax: (631) 675-2001

The NPI 1225034788 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, darbepoetin alfa, 1 microgram (non-esrd use) (HCPCS:J0881)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, iron sucrose, 1 mg (HCPCS:J1756)
• Flow cytometry technique for dna or cell analysis, each additional marker (HCPCS:88185)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Phosphate level (HCPCS:84100)
• Magnesium level (HCPCS:83735)
• Uric acid level, blood (HCPCS:84550)
• Gammaglobulin (immune system protein) measurement (HCPCS:82784)
• Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month (HCPCS:99490)
• Ferritin (blood protein) level (HCPCS:82728)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Protein measurement, serum (HCPCS:84165)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Immunologic analysis technique on serum (immunofixation) (HCPCS:86334)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Flow cytometry technique for dna or cell analysis, first marker (HCPCS:88184)
• Red blood count, manual test (HCPCS:85044)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Blood test, clotting time (HCPCS:85610)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Folic acid level, serum (HCPCS:82746)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Beta-2 microglobulin (protein) level (HCPCS:82232)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Injection of drug or substance into vein (HCPCS:96374)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional (HCPCS:99211)
• Testosterone (hormone) level, total (HCPCS:84403)
• Drawing of blood for a medical problem (HCPCS:99195)
• Hemoglobin a1c level (HCPCS:83036)
• Albumin (protein) level (HCPCS:82040)
• Urinalysis, manual test (HCPCS:81002)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 125 (HCPCS:86304)
• Haptoglobin (serum protein) level (HCPCS:83010)
• Thyroxine (thyroid chemical), total (HCPCS:84436)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Measurement c-reactive protein for detection of infection or inflammation, high sensitivity (HCPCS:86141)
• Transitional care management services for problem of high complexity (HCPCS:99496)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Gene analysis (calreticulin), common variants (HCPCS:81219)
• Gene analysis (janus kinase 2) variant (HCPCS:81270)
• Gene analysis (janus kinase 2) targeted sequence analysis (HCPCS:81279)
• Gene analysis (mpl proto-oncogene, thrombopoietin receptor) for detection of common variants (HCPCS:81338)
• Acute hepatitis panel (HCPCS:80074)
• Bilirubin level, total (HCPCS:82247)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Molecular pathology procedure; physician interpretation and report (HCPCS:G0452)
• Ige (immune system protein) level (HCPCS:82785)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Coagulation assessment blood test, plasma or whole blood (HCPCS:85730)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Rheumatoid factor level (HCPCS:86431)
• Cortisol (hormone) measurement, total (HCPCS:82533)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Comprehensive assessment of and care planning for patients requiring chronic care management services (list separately in addition to primary monthly care management service) (HCPCS:G0506)
• Bilirubin level, direct (HCPCS:82248)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Fibrinogen (factor 1) activity measurement (HCPCS:85384)

The enumeration date for this NPI number is 6/21/2005 and was last updated on 6/1/2015.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: